Related Experiment Video
Updated: Feb 22, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
Nanomedicine 2.0
1Institute of Biomaterials and Biomedical Engineering, Donnelly Center for Cellular and Biomolecular Research, Department of Chemistry, Department of Chemical Engineering, and Department of Materials Science and Engineering, University of Toronto , 160 College Street, 407, Toronto, Ontario M5S 3G9 Canada.
Abstract:
Nanotechnology can profoundly change the way we diagnose and treat diseases, but the ability to control how engineered nanoparticles behave within the body remains largely elusive. This Commentary describes the progress and limitations of nanomedicine and the research and experimental philosophies that should be considered in our quest to advance nanotechnology to the clinic.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drug Discovery: Overview
Microorganisms in Medicine and Therapeutics
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

